ACS
IBB icon

Archford Capital Strategies’s iShares Biotechnology ETF IBB Stock Holding History

Archford Capital Strategies’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,364
Closed -$209K – 305
2021
Q1 		$209K Buy
+1,364
New +$217K 0.06% 259
2019
Q3 		– Sell
-2,128
Closed -$232K – 356
2019
Q2 		$232K Sell
2,128
-451
-17% -$48K 0.08% 200
2019
Q1 		$288K Sell
2,579
-4,850
-65% -$532K 0.11% 195
2018
Q4 		$716K Sell
7,429
-2,616
-26% -$278K 0.29% 104
2018
Q3 		$1.23M Sell
10,045
-749
-7% -$88.2K 0.45% 62
2018
Q2 		$1.19M Sell
10,794
-1,388
-11% -$148K 0.42% 72
2018
Q1 		$1.3M Buy
12,182
+69
+0.6% +$7.65K 0.54% 58
2017
Q4 		$1.29M Sell
12,113
-853
-7% -$91.2K 0.48% 59
2017
Q3 		$1.44M Sell
12,966
-63
-0.5% -$6.73K 0.54% 61
2017
Q2 		$1.35M Buy
13,029
+156
+1% +$15.4K 0.53% 62
2017
Q1 		$1.26M Buy
12,873
+369
+3% +$35.3K 0.47% 64
2016
Q4 		$1.11M Buy
12,504
+144
+1% +$13.1K 0.47% 76
2016
Q3 		$1.19M Buy
12,360
+216
+2% +$20.5K 0.49% 65
2016
Q2 		$1.04M Buy
12,144
+297
+3% +$26.6K 0.55% 55
2016
Q1 		$1.03M Buy
11,847
+2,967
+33% +$265K 0.49% 64
2015
Q4 		$1M Buy
8,880
+189
+2% +$20.5K 0.46% 69
2015
Q3 		$879K Sell
8,691
-195
-2% -$23.4K 0.66% 45
2015
Q2 		$1.09M Buy
8,886
+309
+4% +$37K 0.78% 32
2015
Q1 		$982K Sell
8,577
-1,566
-15% -$173K 0.68% 48
2014
Q4 		$1.03M Buy
10,143
+126
+1% +$12.2K 0.75% 36
2014
Q3 		$914K Buy
10,017
+696
+7% +$61.1K 0.73% 31
2014
Q2 		$799K Buy
9,321
+1,698
+22% +$134K 0.62% 50
2014
Q1 		$601K Buy
+7,623
New +$635K 0.5% 65

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Archford Capital Strategies's IBB Position: Q2 2021 in Review

Archford Capital Strategies sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 1,364 shares — an estimated $209K sold.

Archford Capital Strategies first reported a position in IBB in Q1 2014 and held it in 23 quarters. The position peaked at $1.44M in Q3 2017. 864 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Archford Capital Strategies reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Archford Capital Strategies sold 1,364 iShares Biotechnology ETF shares in Q2 2021, an estimated $209K.
  • Archford Capital Strategies first reported a position in iShares Biotechnology ETF in Q1 2014 and held it in 23 quarters.
  • Archford Capital Strategies's iShares Biotechnology ETF position peaked at $1.44M in Q3 2017.
  • 864 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Archford Capital Strategies's 13F filing for Q2 2021, filed 23 Jul 2021.